The latest closing stock price for Grace Therapeutics as of February 21, 2025 is 3.29.
An investor who bought $1,000 worth of Grace Therapeutics stock at the IPO in 2012 would have $-994 today, roughly -1 times their original investment - a -32.83% compound annual growth rate over 13 years.
The all-time high Grace Therapeutics stock closing price was 1953.60 on August 05, 2013.
The Grace Therapeutics 52-week high stock price is 4.96, which is 50.8% above the current share price.
The Grace Therapeutics 52-week low stock price is 2.13, which is 35.3% below the current share price.
The average Grace Therapeutics stock price for the last 52 weeks is 3.15.
An investor who bought $1,000 worth of Grace Therapeutics stock at the IPO in 2012 would have $-994 today, roughly -1 times their original investment - a -32.83% compound annual growth rate over 13 years.
The all-time high Grace Therapeutics stock closing price was 1953.60 on August 05, 2013.
The Grace Therapeutics 52-week high stock price is 4.96, which is 50.8% above the current share price.
The Grace Therapeutics 52-week low stock price is 2.13, which is 35.3% below the current share price.
The average Grace Therapeutics stock price for the last 52 weeks is 3.15.